Glow-in-the-Dark dye could replace radiation for breast cancer staging

NCT ID NCT07311278

First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 15 times

Summary

This study tests a new method to find sentinel lymph nodes (the first nodes cancer may spread to) in breast cancer patients. Instead of using a radioactive tracer, doctors use a fluorescent dye called indocyanine green that glows under a special camera. The goal is to see if this dye works as well as the current standard, which has drawbacks like radiation exposure and limited availability. About 493 patients from multiple countries are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Antoni van Leeuwenhoek Ziekenhuis

    Amsterdam, Netherlands

  • Bernhoven Ziekenhuis

    Uden, Netherlands

  • Erasmus Medisch Centrum

    Rotterdam, Netherlands

  • FlevoZiekenhuis

    Almere Stad, Netherlands

  • HagaZiekenhuis

    The Hague, Netherlands

  • Isala Ziekenhuis

    Zwolle, Netherlands

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, Netherlands

  • Maastricht Universitair Medisch Centrum

    Maastricht, Netherlands

  • Ospedale Pederzoli

    Peschiera del Garda, Italy

  • Reinier de Graaf Gasthuis

    Delft, Netherlands

  • Van Weel-Bethesda Ziekenhuis

    Dirksland, Netherlands

Conditions

Explore the condition pages connected to this study.